<DOC>
	<DOCNO>NCT02752503</DOCNO>
	<brief_summary>The objective study effectiveness Nalmefene decrease alcohol intake subject alcohol use disorder comorbid BPD .</brief_summary>
	<brief_title>Nalmefene Alcohol Dependence Borderline Personality Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Nalmefene</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Alcohol use disorder accord DSM 5 Borderline personality disorder accord DSM 5 CGIBPD &gt; 3 Female use contraception Other axis I disorder Severe organic disorder Pregnancy breastfeed Allergy Nalmefene Subjects Opioids use disorder treatment opioid agonist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>